Does VOXELOTOR Cause Central venous catheterisation? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Central venous catheterisation have been filed in association with VOXELOTOR (OXBRYTA). This represents 0.1% of all adverse event reports for VOXELOTOR.
22
Reports of Central venous catheterisation with VOXELOTOR
0.1%
of all VOXELOTOR reports
0
Deaths
14
Hospitalizations
How Dangerous Is Central venous catheterisation From VOXELOTOR?
Of the 22 reports, 14 (63.6%) required hospitalization.
Is Central venous catheterisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VOXELOTOR. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does VOXELOTOR Cause?
Sickle cell anaemia with crisis (11,023)
Product dose omission issue (5,122)
Diarrhoea (3,173)
Off label use (2,364)
Nausea (2,003)
Headache (1,683)
Abdominal pain upper (1,165)
Pain (1,059)
Therapy cessation (1,038)
Fatigue (1,004)
What Other Drugs Cause Central venous catheterisation?
EPOPROSTENOL (361)
AMBRISENTAN (263)
TREPROSTINIL (208)
ECULIZUMAB (105)
VENETOCLAX (89)
MACITENTAN (78)
PEMBROLIZUMAB (70)
AZTREONAM LYSINE (63)
ADALIMUMAB (59)
NATALIZUMAB (57)
Which VOXELOTOR Alternatives Have Lower Central venous catheterisation Risk?
VOXELOTOR vs VUTRISIRAN
VOXELOTOR vs VX-770
VOXELOTOR vs VX-950
VOXELOTOR vs VYVANSE
VOXELOTOR vs WARFARIN